Vimarsana
Biggest News Aggregation in the World

Advanced Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advanced Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advanced Malignancies Today - Breaking & Trending Today

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 - Vimarsana News

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024

Published: May 24, 2024

STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May

Source: finanznachrichten.de
Related Topics:
United StatesSan AntonioUnited KingdomJustin MoserJordi Rodon AhnertKyriakos PapadopoulosJosefin Beate HolzHonorhealth Research InstituteAmerican Society Of Clinical OncologyTherapeutics LtdStorm Therapeutics LtdIp GroupUtokyo Innovation Platform Co LtdFast Track InitiativeJustin Moser At Honorhealth Research InstituteSeroba Life SciencesCambridge Innovation CapitalUniversity Of Texas Md Anderson Cancer CenterTaiho VenturesAmerican SocietyClinical OncologyAnnual MeetingCohort Expansion Study Evaluating SafetyClinical ActivityAdvanced Malignancies
Alpine Immune Sciences Announces Presentations at the 2022 EULAR and ASCO Annual Meetings - Vimarsana News

Alpine Immune Sciences Announces Presentations at the 2022 EULAR and ASCO Annual Meetings

Published: May 27, 2022

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
United StatesAlex SharifKelli PerkinsEuropean CongressAmerican Society Of Clinical OncologyAlpine Immune SciencesAlpine Immune Sciences IncMerck Sharp Dohme CorpExchange CommissionMerck Co IncCorporate DevelopmentSecurities ExchangeImmune SciencesAnnual CongressClinical OncologyAnnual MeetingEngineered DualPotently Inhibits Pathogenic AutoantibodiesPreclinical ModelsCorresponding Pharmacodynamic ActivityDisplay DetailsDual Checkpoint InhibitorAdvanced MalignanciesScientific PublicationsSecurities Act
Sarah Cannon Research Institute: Sarah Cannon to Present Latest Cancer Research Insights at 2021 ASCO Annual Meeting - Vimarsana News

Sarah Cannon Research Institute: Sarah Cannon to Present Latest Cancer Research Insights at 2021 ASCO Annual Meeting

Published: June 4, 2021

119 Abstracts and Presentations Featuring Sarah Cannon's Clinical Research and Care Insights Today, Sarah Cannon announced it will present its latest cancer research insights at the American Society

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomDebra RichardsonTodd BauerCarissa JonesMelisa FontanaGerald FalchookAndrew MckenzieManish PatelGemma SturgillMaen HusseinRebecca GelmanMarlana OrloffJudy WangJesus BerdejaAndrew KennedyTrastuzumab DeruxtecanMelissa JohnsonDee Anna SmithMeredith MckeanDavid SpigelFludarabine CyclophosphamideDax KurbegovKostenloser WertpapierhandelLucitanib Nivolumab